d) at Clairo

Hanover, Lower-Saxony, Germany

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Automotive, ManufacturingIndustries

Requirements

Master’s degree in a relevant field
Several years of professional experience in consulting, corporate strategy, strategic planning, business development, or new ventures, ideally within the automotive or battery industry
Proven ability to lead large-scale transformation projects (e.g., M&A) and structure complex challenges into fact-based recommendations
Strong ability to constructively engage senior management in brainstorming and evaluating growth ideas, both formally and informally
Demonstrated success in building and maintaining effective relationships with senior customers, consultants, and industry stakeholders
Ability to influence and facilitate activities in global environments
Experience in working in both direct and matrix management environments
Proven ability to optimize core businesses while driving growth strategies
Collaborative mindset with success in participative management environments
Strong and inspiring team player with the ability to motivate, engage, and energize colleagues
Excellent business judgment, high professional standards, and a strong presence with the ability to challenge established thinking constructively
High credibility with internal and external stakeholders, instilling confidence and trust
Fluency in English, both written and spoken; additional European languages are a plus
Willingness to travel up to 15%

Responsibilities

Assessing and prioritizing key markets, customers, competitive and technology dynamics, and cost drivers impacting Clarios
Evaluating requirements and business models to establish critical success factors and drive growth, including joint ventures and M&A opportunities
Determining Clarios’ positioning, gaps, and requirements against these factors
Developing actionable strategies and tactics to drive growth
Structuring issues and frameworks for senior leaders, parent-company representatives, and/or Board members
Driving the yearly update of the EMEA multi-year strategic plan in close alignment with the global organization
Collaborating with Finance and other stakeholders to improve process quality, cadence, and results (e.g., sales, CAPEX)
Synthesizing the plan for senior leadership and deriving strategic actions in the Strategic Plan or EMEA Incubator
Preparing regular Strategy Deployment meetings with regional Top Management
Tracking progress and impact of strategic initiatives
Leading selected cross-functional projects and initiatives within the EMEA Strategic Plan and Incubator
Identifying new strategic opportunities and cost-saving measures

Skills

Strategic Planning

Market Analysis

Competitive Analysis

M&A Evaluation

Business Modeling

Growth Strategy

Cross-functional Collaboration

Financial Analysis

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free